Dr. Xing-Jie Liang graduated at Department of Microbiology, College of Life Science, NanKai University and got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman (Deputy Director of NIH, USA) at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS (National Institute of Neurological Diseases and Strokes, NIH) for 2 years. In 2007, he was an Assistant professor at Department of Radiology, School of Medicine, Howard University. Dr. Liang currently is deputy director of Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and a principal investigator at Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology of China. Dr. Liang is a founder member of International Society of Nanomedicine, member of American Association for Cancer Research, and member of American Society of Cell Biology. Dr. Liang is current editorial board member of Biophysics Report, Advances in Nano Research, current nanoscience, Biomaterials Research, Theranostics and guest editor of Biotechnology Advances. Dr. Liang organized the International Symposium of Nanomedicine on AIDS (ISNA-2009) at Beijing, he is also Chairman of Organizing Committee of China-US Bilateral Symposium of Cancer Nanotechnology and Nanomedicine (2008, 2010，2012).

Dr. Xing-Jie Liang's research interests focus on: Nanochemotherapy Nanobiomedicinal Therapy Nanobiotechnology Nanoimaging